PL366204A1 - Postacie dawkowania apomorfiny przez śluzówkę jamy ustnej - Google Patents

Postacie dawkowania apomorfiny przez śluzówkę jamy ustnej

Info

Publication number
PL366204A1
PL366204A1 PL00366204A PL36620400A PL366204A1 PL 366204 A1 PL366204 A1 PL 366204A1 PL 00366204 A PL00366204 A PL 00366204A PL 36620400 A PL36620400 A PL 36620400A PL 366204 A1 PL366204 A1 PL 366204A1
Authority
PL
Poland
Prior art keywords
apomorphine
dosage forms
oral mucosal
mucosal dosage
oral
Prior art date
Application number
PL00366204A
Other languages
English (en)
Inventor
Paul E. Stach
Craig W. Davis
Raymundo A. Sison
Robert K. Mansfield
John D. Bollinger
Pramod K. Gupta
Original Assignee
Tap Holdings, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tap Holdings, Inc. filed Critical Tap Holdings, Inc.
Publication of PL366204A1 publication Critical patent/PL366204A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
PL00366204A 1999-12-30 2000-12-19 Postacie dawkowania apomorfiny przez śluzówkę jamy ustnej PL366204A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47584499A 1999-12-30 1999-12-30
PCT/US2000/034548 WO2001049292A1 (en) 1999-12-30 2000-12-19 Oral mucosal dosage forms of apomorphine

Publications (1)

Publication Number Publication Date
PL366204A1 true PL366204A1 (pl) 2005-01-24

Family

ID=23889387

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00366204A PL366204A1 (pl) 1999-12-30 2000-12-19 Postacie dawkowania apomorfiny przez śluzówkę jamy ustnej

Country Status (14)

Country Link
EP (1) EP1242088A1 (pl)
JP (1) JP2004501065A (pl)
CN (1) CN1414853A (pl)
AU (1) AU2440901A (pl)
BR (1) BR0012822A (pl)
CA (1) CA2394297A1 (pl)
CZ (1) CZ20022245A3 (pl)
HK (1) HK1051315A1 (pl)
HU (1) HUP0400495A3 (pl)
IL (1) IL150034A0 (pl)
MX (1) MXPA02006034A (pl)
NO (1) NO20023190L (pl)
PL (1) PL366204A1 (pl)
WO (1) WO2001049292A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0202365D0 (sv) 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
EA012306B1 (ru) * 2003-01-24 2009-08-28 Магле Холдинг Аб Композиционный материал для доставки через слизистые оболочки
CA2562391A1 (en) 2004-04-14 2005-10-27 Takeda Pharmaceutical Company Limited Solid pharmaceutical preparation
GB0509317D0 (en) * 2005-05-06 2005-06-15 Clarke Anthony Pharmaceutical formulation of apomorphine
US9044475B2 (en) * 2009-06-12 2015-06-02 Cynapsus Therapeutics, Inc. Sublingual apomorphine
US20220249465A1 (en) * 2019-05-31 2022-08-11 Primo Pharmatech Llc Unit dosage form for transmucosal drug delivery of an active pharmaceutical ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0689438T3 (da) * 1993-03-26 2003-09-29 Franciscus Wilhelmus He Merkus Farmaceutiske præparater til intranasal administration af apomorfin
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions

Also Published As

Publication number Publication date
EP1242088A1 (en) 2002-09-25
CN1414853A (zh) 2003-04-30
MXPA02006034A (es) 2004-08-23
BR0012822A (pt) 2004-03-09
HUP0400495A3 (en) 2007-05-02
CZ20022245A3 (cs) 2002-10-16
NO20023190L (no) 2002-08-29
JP2004501065A (ja) 2004-01-15
HUP0400495A2 (hu) 2004-06-28
AU2440901A (en) 2001-07-16
HK1051315A1 (zh) 2003-08-01
NO20023190D0 (no) 2002-07-01
WO2001049292A1 (en) 2001-07-12
CA2394297A1 (en) 2001-07-12
IL150034A0 (en) 2002-12-01

Similar Documents

Publication Publication Date Title
HUP0203204A3 (en) Oral dosage forms
IL140451A0 (en) Extended release oral dosage composition
IL136901A0 (en) Flash-melt oral dosage formulation
AU6089200A (en) Rapid immediate release oral dosage form
EG23759A (en) Stable extended release oral dosage composition
ZA200202480B (en) Oral dosage forms.
AU1998200A (en) Multiparticulate oral dosage forms
EP1372392A4 (en) ORAL DOSAGE FORM CONTAINING NICOTINE
IL208892A0 (en) Use of hmg fragment as anti-inflammatory agents
PL356358A1 (en) Solid dosage form of someticone for oral administration
AU2001249329A1 (en) Lipoxin analogs and methods for the treatment of periodontal disease
AU2003238670A8 (en) Fast disintegrating oral dosage forms
IL138192A0 (en) Controlled release oral dosage forms
HUP0500638A3 (en) Flashmelt oral dosage formulation
PL340456A1 (en) Novel oral dosage form of carvedilol
IL150034A0 (en) Oral mucosal dosage forms of apomorphine
HUP0201667A3 (en) Oral form of administration
GB9923045D0 (en) New oral formulations
HUP0401599A3 (en) Extended release oral dosage form
HUP0301891A3 (en) Oral composition
GB9925069D0 (en) Oral dosage form
IL132006A0 (en) Stable pharmaceuticl oral dosage forms
GB0014497D0 (en) Oral dosage form
GB9911839D0 (en) Invention related to oral hygiene
GB0030587D0 (en) Oral administration of beneficial substances

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)